mRNA vaccines induce a higher antibodies response in children with previous COVID-19
Management of Mpox in people with HIV attending a sexual health department in London, UK
SARS-COV-2 in children & adolescents living with HIV in Europe & South Africa
Persistent symptoms in children admitted with COVID similar to controls 1 year later
Comorbidities that increase risk for severe acute COVID-19 in pediatric population
Pediatric coronavirus disease 2019 in Africa
PentaTr@ining: ‘AMR Online Course’ kicks-off!
Register for the webinar “Protecting our tiniest patients: Strategies for managing NICU outbreaks”
Perinatal characteristics and longer-term outcomes in Brazilian children with confirmed or suspected congenital Zika infection: ZIKAction Paediatric Registry
An optimised dosing regimen vs. a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in infants less than 90 days: the NeoVanc trial
Interim pharmacokinetic analysis of a multi-centre randomised open label phase IIb study in neonates to validate the meta-analysis population pharmacokinetic model used to simulate an optimised dosing regimen in neonates and infants aged < 90 days: the NeoVanc trial
MRC Clinical Trials Unit Capacity Strengthening Hub launches!
